Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Fresenius NaturaLyte Recall Expanded Due to Bacterial Contamination Risk May 23, 2014 Irvin Jackson Add Your Comments The bacterial contamination that caused a recall of NaturaLyte liquid bicarbonate concentrate last month has been identified and Fresenius Medical Care has expanded the recall due to the risk of severe injuries or death among dialysis patients.  On May 21, Fresenius Medical Care North America expanded a NaturaLyte recall first issued in April, due to bacterial contamination. The company announced that the bicarbonate concentrate, used in dialysis procedures, was contaminated with a bacteria called Halomonas, and that the FDA has classified the decision to remove of the 56 lots of affected NaturaLyte as a Class I recall, suggesting that continued use of the product may carry a risk of severe adverse health outcomes or death. Learn More About Fresenius Dialysis Treatment Lawsuit Heart attacks, deaths during hemodialysis may be caused by Granuflo, NaturaLyte. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Fresenius Dialysis Treatment Lawsuit Heart attacks, deaths during hemodialysis may be caused by Granuflo, NaturaLyte. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The recall was first announced in a letter sent to healthcare professionals on April 10. A second letter was sent out earlier this month, the company said. Fresenius reports that Halomonas is a Gram Negative bacteria that is usually found in water with high levels of salt. Exposure to Halomonas in NaturaLyte could lead to bacteremia or systemic infection, and patients requiring dialysis may be more vulnerable to such infections. However, Fresenius notes that the dialysis procedure utilizes both the dialysis filter, known as a dialyzer, and the use of the Diasafe filter or an equivalent which makes infection unlikely. The NaturaLyte recall expansion increases the amount recalled from 49 lots to 56 lots of NaturaLyte Bicarbonate Concentrate sold in 6.4 liter bottles, which were distributed between August 15, 2013 and April 7, 2014. The affected lots contain a product code of 08-4000-LB, with expiration dates of 6/30/2014, 7/31/2014, 8/31/2014, and 12/31/2014. Fresenius warns that bacterial contamination could cause pyrogenic reactions from endotoxins present in bacteria, which can lead to fever, hypotension, flushing, chills, and potentially trouble breathing. While most of these symptoms are short-term, contamination could also lead to long-term health consequences. The manufacturer has requested that dialysis clinics with bottles of NaturaLyte affected by the recall discontinue use immediately, place the recalled bicarbonate concentrate in a secure, segregated area, perform a [Heat Disinfect] program on any machine on which affected product was used, and contact a Fresenius service team by calling (800) 323-5188 for instructions on how to return the recalled NaturaLyte. The letters included a reply form the company wanted customers to fill out and return as well. NaturaLyte Heart Attack Lawsuits The recall comes a little more than two years after it was discovered that Fresenius withheld important safety information about the risk of cardiac arrest linked to the use of NaturaLyte and another dialysate solution known as Granuflo, a dry acid concentrate. Fresenius Medical Care not only makes many of the products used during dialysis treatment, but also operates many of the clinics in the U.S. In November 2011, the company sent an internal memo to their own clinics warning about the importance of doctors monitoring bicarbonate levels during treatments, since side effects of Naturlyte and Granuflo may cause higher than expected bicarbonate levels and cause dialysis patients to suffer a sudden cardiac arrest or death. While Fresenius provided these warnings to their own clinics, the information was withheld from other dialysis clinics using the products. After the internal memo was leaked to the FDA, Fresenius finally provided warnings to the entire medical community in March 2012, which the FDA classified as a NaturaLyte and GranuFlo recall. More than 1,500 Fresenius dialysis treatment lawsuits are now being pursued by individuals throughout the United States who allege that sudden cardiac arrest or death following hemodialysis was caused by use of NaturaLyte or Granuflo. In the federal court system, the litigation has been centralized before U.S. District Judge Douglas P. Woodlock in the District of Massachusetts for coordinated handling during pretrial proceedings and a series of bellwether trials designed to gauge how juries are likely to respond to certain evidence and testimony that will be similar to what is offered in hundreds of other cases. Tags: Bacterial Contamination, Dialysis, Fresenius, Granuflo, Heart Attack, Infection, NaturaLyte Image Credit: | More Fresenius Dialysis Lawsuit Stories DaVita Dialysis Lawsuit Over Cardiac Arrests Results in $383.5M Verdict June 28, 2018 Fresenius Dialysis Trial Results in Defense Verdict After Opting Out of Settlement March 6, 2017 Lawsuit Over Fresenius Dialysis Treatments Filed by Kentucky A.G. September 7, 2016 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: yesterday) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 2 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025) BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 3 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: yesterday) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 2 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 3 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)